Genome Editing/Genome Engineering Market by Technology (TALEN, CRISPR, ZFN), Application (Animal Genetic Engineering, Cell Line Engineering, Plant Genetic Engineering), End User (Pharmaceutical & Biotechnology Companies, CROs) – 2019 2024

$3,850.00$5,850.00

AVAIL 20% DISCOUNT ON PURCHASE OF ANY REPORT
Published on: June 2, 2019
Clear
SKU: GMS830 Category:

The global market for genome engineering is projected to reach USD 7.34 billion by 2024, with a CAGR growth of 13.76% during the forecast period. Growing government funding and growth in the number of Genomics projects high prevalence of infectious diseases and cancer, increased production of genetically modified crops and -genomics applications are key factors driving the growth of this market

Genome Editing/Genome Engineering Market by Technology (TALEN, CRISPR, ZFN), Application (Animal Genetic Engineering, Cell Line Engineering, Plant Genetic Engineering), End User (Pharmaceutical & Biotechnology Companies, CROs) - 2019 2024 1

Genome Editing/Genome Engineering Market by Technology (TALEN, CRISPR, ZFN), Application (Animal Genetic Engineering, Cell Line Engineering, Plant Genetic Engineering), End User (Pharmaceutical & Biotechnology Companies, CROs) - 2019 2024 2

Genome Editing/Genome Engineering Market by Technology (TALEN, CRISPR, ZFN), Application (Animal Genetic Engineering, Cell Line Engineering, Plant Genetic Engineering), End User (Pharmaceutical & Biotechnology Companies, CROs) - 2019 2024 3

Genome Editing/Genome Engineering Market by Technology (TALEN, CRISPR, ZFN), Application (Animal Genetic Engineering, Cell Line Engineering, Plant Genetic Engineering), End User (Pharmaceutical & Biotechnology Companies, CROs) - 2019 2024 4

Genome Editing/Genome Engineering Market by Technology (TALEN, CRISPR, ZFN), Application (Animal Genetic Engineering, Cell Line Engineering, Plant Genetic Engineering), End User (Pharmaceutical & Biotechnology Companies, CROs) - 2019 2024 5

Genome Editing/Genome Engineering Market by Technology (TALEN, CRISPR, ZFN), Application (Animal Genetic Engineering, Cell Line Engineering, Plant Genetic Engineering), End User (Pharmaceutical & Biotechnology Companies, CROs) - 2019 2024 6

Genome Editing/Genome Engineering Market by Technology (TALEN, CRISPR, ZFN), Application (Animal Genetic Engineering, Cell Line Engineering, Plant Genetic Engineering), End User (Pharmaceutical & Biotechnology Companies, CROs) - 2019 2024 7

Genome Editing/Genome Engineering Market by Technology (TALEN, CRISPR, ZFN), Application (Animal Genetic Engineering, Cell Line Engineering, Plant Genetic Engineering), End User (Pharmaceutical & Biotechnology Companies, CROs) - 2019 2024 8

1 Global Genome Editing/Genome Engineering Market 
1.1 Study Objectives
1.2 Market Definition
1.3 Study Scope
1.3.1 Markets Covered
1.3.2 Geographic Scope

2 RESEARCH METHODOLOGY
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.1.2.3 Breakdown of Primaries
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Research Assumptions

3 Global Genome Editing/Genome Engineering Market – Executive Summary
3.1 Market Revenue, Market Size and Key Trends by Company
3.2 Key Trends by type of Application
3.3 Key Trends segmented by Geography

4 Global Genome Editing/Genome Engineering Market – Comparative Analysis
4.1 Product Benchmarking – Top 10 companies
4.2 Top 5 Financials Analysis
4.3 Market Value split by Top 10 companies
4.4 Patent Analysis – Top 10 companies
4.5 Pricing Analysis

5 Global Genome Editing/Genome Engineering Market – Industry Market Entry Scenario
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis – Top 10 companies

6 Global Genome Editing/Genome Engineering Market – Market Forces
6.1 Introduction
6.2 Market Dynamics
6.2.1 Drivers
6.2.2 Opportunities
6.2.3 Challenges
6.3 Porters Analysis of Market
6.3.1 Bargaining power of suppliers
6.3.2 Bargaining powers of customers
6.3.3 Threat of new entrants
6.3.4 Rivalry among existing players
6.3.5 Threat of substitutes

7 Global Genome Editing/Genome Engineering Market – Strategic Analysis
7.1 Value Chain analysis
7.2 Product Life Cycle
7.3 Supplier and distributor analysis (Market share and product dealing strategies)

8 Global Genome Editing/Genome Engineering Market – By Technology (Market Size – & million/billion)
8.1 CRISPR
8.2 TALEN
8.3 ZFN
8.4 Antisense
8.5 Other

9 Global Genome Editing/Genome Engineering Market – By Application
9.1 Cell line Engineering
9.2 Genetic Engineering
9.3 Other

10 Global Genome Editing/Genome Engineering Market – By End-User
10.1 Pharmaceutical & Biotechnology Companies
10.2 Academic & Research Institutes
10.3 Contract Research Organizations

11 Global Genome Editing/Genome Engineering Market – By Geography (Market Size – & million/billion)
11.1 Introduction
11.2 North America
11.2.1 US
11.2.2 Canada
11.2.3 Mexico
11.3 Europe
11.3.1 U.K
11.3.2 Germany
11.3.3 Italy
11.3.4 France
11.3.5 Spain
11.3.6 Rest of Europe
11.4 Asia-Pacific
11.4.1 China
11.4.2 Japan
11.4.3 India
11.4.4 South Korea
11.4.5 Rest of APAC
11.5 Rest of the World
11.5.1 South America
11.5.2 Middle East
11.5.3 Africa

12 Global Genome Editing/Genome Engineering Market – Entropy
12.1 New product launches
12.2 M&A’s, collaborations, JVs and partnerships

13 Global Genome Editing/Genome Engineering Market Company Profile (Key Players)
13.1 Market Share, Company Revenue, Products, M&A, Developments
13.2 Thermo Fisher Scientific
13.3 Merck
13.4 Transposagen Biopharmaceuticals
13.5 Editas Medicine
13.6 Horizon Discovery Group
13.7 Genscript
13.8 Sangamo Biosciences
13.9 Crispr Therapeutics
13.10 New England Biolabs
13.11 Origene Technologies
13.12 Company 11 & more

14 Global Genome Editing/Genome Engineering Market – Appendix
14.1 Sources
14.2 Abbreviations